• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双打击淋巴瘤:对一系列巴西高级别非霍奇金淋巴瘤患者的临床、形态学、免疫组织化学和细胞遗传学研究

Double-hit lymphomas: clinical, morphological, immunohistochemical and cytogenetic study in a series of Brazilian patients with high-grade non-Hodgkin lymphoma.

作者信息

Oliveira Cristiano Claudino, Maciel-Guerra Helena, Kucko Luan, Hirama Eric Jun, Brilhante Américo Delgado, Quevedo Francisco Carlos, da Cunha Isabela Werneck, Soares Fernando Augusto, Niero-Melo Ligia, Dos Reis Patrícia Pintor, Domingues Maria Aparecida Custodio

机构信息

Department of Pathology, Botucatu School of Medicine, São Paulo State University (FMB UNESP), Botucatu, São Paulo, Brazil.

Departamento de Patologia, Faculdade de Medicina de Botucatu (FMB), Universidade Estadual Paulista (UNESP), Distrito de Rubião Junior, s/n°, Botucatu, SP, Zip code: 18618-000, Brazil.

出版信息

Diagn Pathol. 2017 Jan 7;12(1):3. doi: 10.1186/s13000-016-0593-0.

DOI:10.1186/s13000-016-0593-0
PMID:28061782
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5219810/
Abstract

BACKGROUND

Double-hit lymphomas (DHL) are rare high-grade neoplasms characterized by two translocations: one involving the gene MYC and another involving genes BCL2 or BCL6, whose diagnosis depends on cytogenetic examination. This research studied DHL and morphological and/or immunophenotypic factors associated with the detection of these translocations in a group of high-grade non-Hodgkin lymphoma cases.

METHOD

Clinical and morphological reviews of 120 cases diagnosed with diffuse large B-cell lymphoma and Burkitt lymphoma were conducted. Immunohistochemistry (CD20, CD79a, PAX5, CD10, Bcl6, Bcl2, MUM1, TDT and Myc) and fluorescence in situ hybridization for detection of MYC, BCL2 and BCL6 gene translocations were performed in a tissue microarray platform.

RESULTS

Three cases of DHL were detected: two with translocations of MYC and BCL2 and one with translocations of MYC and BCL6, all leading to death in less than six months. Among 90 cytogenetically evaluable biopsies, associations were determined between immunohistochemistry and fluorescence in situ hybridization for MYC (p = 0.036) and BCL2 (p = 0.001). However, these showed only regular agreement, indicated by Kappa values of 0.23 [0.0;0.49] and 0.35 [0.13;0.56], respectively. "Starry sky" morphology was strongly associated with MYC positivity (p = 0.01). The detection of three cases of DHL, all resulting in death, confirms the rarity and aggressiveness of this neoplasm.

CONCLUSIONS

The "starry sky" morphological pattern and immunohistochemical expression of Myc and Bcl2 represent possible selection factors for additional cytogenetic diagnostic testing.

摘要

背景

双打击淋巴瘤(DHL)是罕见的高级别肿瘤,其特征为两种易位:一种涉及MYC基因,另一种涉及BCL2或BCL6基因,其诊断依赖于细胞遗传学检查。本研究在一组高级别非霍奇金淋巴瘤病例中研究了DHL以及与这些易位检测相关的形态学和/或免疫表型因素。

方法

对120例诊断为弥漫性大B细胞淋巴瘤和伯基特淋巴瘤的病例进行临床和形态学回顾。在组织微阵列平台上进行免疫组织化学(CD20、CD79a、PAX5、CD10、Bcl6、Bcl2、MUM1、TDT和Myc)以及用于检测MYC、BCL2和BCL6基因易位的荧光原位杂交。

结果

检测到3例DHL病例:2例为MYC和BCL2易位,1例为MYC和BCL6易位,所有病例均在不到6个月内死亡。在90例可进行细胞遗传学评估的活检标本中,确定了免疫组织化学与MYC(p = 0.03)和BCL2(p = 0.001)荧光原位杂交之间的相关性。然而,这些仅显示出一般一致性,Kappa值分别为0.23 [0.0;0.49]和0.35 [0.13;0.56]。“星空”形态与MYC阳性密切相关(p = 0.01)。3例DHL病例的检测结果均导致死亡,证实了该肿瘤的罕见性和侵袭性。

结论

“星空”形态模式以及Myc和Bcl2的免疫组织化学表达代表了进行额外细胞遗传学诊断检测的可能选择因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f823/5219810/7c694d906653/13000_2016_593_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f823/5219810/7c694d906653/13000_2016_593_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f823/5219810/7c694d906653/13000_2016_593_Fig1_HTML.jpg

相似文献

1
Double-hit lymphomas: clinical, morphological, immunohistochemical and cytogenetic study in a series of Brazilian patients with high-grade non-Hodgkin lymphoma.双打击淋巴瘤:对一系列巴西高级别非霍奇金淋巴瘤患者的临床、形态学、免疫组织化学和细胞遗传学研究
Diagn Pathol. 2017 Jan 7;12(1):3. doi: 10.1186/s13000-016-0593-0.
2
Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.致癌基因重排模式对双打击非霍奇金淋巴瘤患者预后的影响。
Cancer. 2016 Feb 15;122(4):559-64. doi: 10.1002/cncr.29781. Epub 2015 Nov 13.
3
Clinical significance of 'double-hit' and 'double-expression' lymphomas.“双打击”和“双表达”淋巴瘤的临床意义。
J Clin Pathol. 2020 Mar;73(3):126-138. doi: 10.1136/jclinpath-2019-206199. Epub 2019 Oct 15.
4
[B-cell lymphomas with concurrent myc and bcl-2/IgH or bcl-6 translocations].伴有myc与bcl-2/IgH或bcl-6同时易位的B细胞淋巴瘤
Zhonghua Bing Li Xue Za Zhi. 2013 Sep;42(9):584-8.
5
Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.具有 BCL6 和 MYC 易位的双打击 B 细胞淋巴瘤是侵袭性的,常为结外淋巴瘤,与 BCL2 双打击 B 细胞淋巴瘤不同。
Am J Surg Pathol. 2013 Mar;37(3):323-32. doi: 10.1097/PAS.0b013e31826cebad.
6
EBV high-grade B cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a multi-institutional study.EBV 阳性高级别 B 细胞淋巴瘤伴 MYC 和 BCL2 及/或 BCL6 重排:一项多机构研究。
Histopathology. 2022 Feb;80(3):575-588. doi: 10.1111/his.14585. Epub 2021 Dec 16.
7
Lymphomas with pseudo-double-hit BCL6-MYC translocations due to t(3;8)(q27;q24) are associated with a germinal center immunophenotype, extranodal involvement, and frequent BCL2 translocations.由于 t(3;8)(q27;q24)导致的具有假性双打击 BCL6-MYC 易位的淋巴瘤与生发中心免疫表型、结外累及和频繁的 BCL2 易位有关。
Hum Pathol. 2018 Oct;80:192-200. doi: 10.1016/j.humpath.2018.06.006. Epub 2018 Jun 11.
8
High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.伴有MYC重排且无BCL2和BCL6重排的高级别B细胞淋巴瘤与P53高表达及预后不良相关。
Am J Surg Pathol. 2016 Feb;40(2):253-61. doi: 10.1097/PAS.0000000000000542.
9
Prognostic impact of diffuse large B-cell lymphoma with extra copies of MYC, BCL2 and/or BCL6: comparison with double/triple hit lymphoma and double expressor lymphoma.弥漫性大 B 细胞淋巴瘤中 MYC、BCL2 和/或 BCL6 额外拷贝的预后影响:与双/三打击淋巴瘤和双表达淋巴瘤的比较。
Diagn Pathol. 2019 Jul 17;14(1):81. doi: 10.1186/s13000-019-0856-7.
10
Diagnostic Approach for Double-Hit and Triple-Hit Lymphoma Based on Immunophenotypic and Cytogenetic Characteristics of Bone Marrow Specimens.基于骨髓标本免疫表型和细胞遗传学特征的双打击和三打击淋巴瘤的诊断方法。
Ann Lab Med. 2020 Sep;40(5):361-369. doi: 10.3343/alm.2020.40.5.361.

引用本文的文献

1
c-MYC and p53 expression highlight starry-sky pattern as a favourable prognostic feature in R-CHOP-treated diffuse large B-cell lymphoma.c-MYC 和 p53 表达呈星空模式,这是 R-CHOP 治疗弥漫性大 B 细胞淋巴瘤的有利预后特征。
J Pathol Clin Res. 2021 Nov;7(6):604-615. doi: 10.1002/cjp2.223. Epub 2021 Aug 9.
2
Double Hit and Double Expresser Diffuse Large B Cell Lymphoma Subtypes: Discrete Subtypes and Major Predictors of Overall Survival.双打击和双表达弥漫性大B细胞淋巴瘤亚型:不同的亚型及总生存的主要预测因素
Indian J Hematol Blood Transfus. 2020 Oct;36(4):627-634. doi: 10.1007/s12288-019-01248-w. Epub 2020 Jan 8.
3

本文引用的文献

1
MYC translocation and/or BCL 2 protein expression are associated with poor prognosis in diffuse large B-cell lymphoma.MYC易位和/或BCL 2蛋白表达与弥漫性大B细胞淋巴瘤的不良预后相关。
Cancer Sci. 2016 Jun;107(6):853-61. doi: 10.1111/cas.12942. Epub 2016 May 6.
2
The 2016 revision of the World Health Organization classification of lymphoid neoplasms.《世界卫生组织淋巴组织肿瘤分类(2016年修订版)》
Blood. 2016 May 19;127(20):2375-90. doi: 10.1182/blood-2016-01-643569. Epub 2016 Mar 15.
3
An oncogenic role for alternative NF-κB signaling in DLBCL revealed upon deregulated BCL6 expression.
HIV-Associated "Double-Hit" Lymphoma of the Tonsil: A First Reported Case.
HIV 相关扁桃体“双打击”淋巴瘤:首例报告。
Head Neck Pathol. 2020 Dec;14(4):1129-1133. doi: 10.1007/s12105-020-01135-1. Epub 2020 Jan 29.
4
C-MYC and BCL2: Correlation between Protein Over-Expression and Gene Translocation and Impact on Outcome in Diffuse Large B Cell Lymphoma.C-MYC与BCL2:弥漫性大B细胞淋巴瘤中蛋白过表达与基因易位的相关性及其对预后的影响
Asian Pac J Cancer Prev. 2019 May 25;20(5):1463-1470. doi: 10.31557/APJCP.2019.20.5.1463.
在BCL6表达失调时揭示了非经典NF-κB信号通路在弥漫性大B细胞淋巴瘤中的致癌作用。
Cell Rep. 2015 May 5;11(5):715-26. doi: 10.1016/j.celrep.2015.03.059. Epub 2015 Apr 23.
4
Diagnosis of 'double hit' diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC.“双打击”弥漫性大B细胞淋巴瘤及具有弥漫性大B细胞淋巴瘤和伯基特淋巴瘤之间特征的不可分类B细胞淋巴瘤的诊断:时机与方法,荧光原位杂交(FISH)与免疫组化(IHC)对比
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):90-9. doi: 10.1182/asheducation-2014.1.90. Epub 2014 Nov 18.
5
Scoring of MYC protein expression in diffuse large B-cell lymphomas: concordance rate among hematopathologists.弥漫性大 B 细胞淋巴瘤中 MYC 蛋白表达的评分:血液病理学家之间的一致性率。
Mod Pathol. 2015 Apr;28(4):545-51. doi: 10.1038/modpathol.2014.140. Epub 2014 Nov 28.
6
New immunohistochemistry for B-cell lymphoma and Hodgkin lymphoma.用于B细胞淋巴瘤和霍奇金淋巴瘤的新型免疫组织化学技术。
Arch Pathol Lab Med. 2014 Dec;138(12):1666-72. doi: 10.5858/arpa.2014-0058-RA.
7
MYC expression in concert with BCL2 and BCL6 expression predicts outcome in Chinese patients with diffuse large B-cell lymphoma, not otherwise specified.MYC与BCL2及BCL6的协同表达可预测中国弥漫性大B细胞淋巴瘤患者(未另作特殊说明)的预后。
PLoS One. 2014 Aug 4;9(8):e104068. doi: 10.1371/journal.pone.0104068. eCollection 2014.
8
Double hit lymphoma: the MD Anderson Cancer Center clinical experience.双打击淋巴瘤:MD 安德森癌症中心的临床经验。
Br J Haematol. 2014 Sep;166(6):891-901. doi: 10.1111/bjh.12982. Epub 2014 Jun 18.
9
'Double-Hit' cytogenetic status may not be predicted by baseline clinicopathological characteristics and is highly associated with overall survival in B cell lymphoma patients.“双打击”细胞遗传学状态可能无法通过基线临床病理特征预测,并且与 B 细胞淋巴瘤患者的总生存高度相关。
Br J Haematol. 2014 Aug;166(3):369-74. doi: 10.1111/bjh.12901. Epub 2014 Apr 25.
10
MYC and BCL2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with rituximab.MYC 和 BCL2 蛋白表达可预测接受利妥昔单抗治疗的弥漫性大 B 细胞淋巴瘤患者的生存情况。
Br J Haematol. 2014 May;165(3):382-91. doi: 10.1111/bjh.12763. Epub 2014 Feb 8.